Jacobs Levy Equity Management’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-54,152
| Closed | -$1.63M | – | 1076 |
|
|
2021
Q3 | $1.63M | Sell |
54,152
-21,840
| -29% | -$655K | 0.01% | 654 |
|
|
2021
Q2 | $3.53M | Buy |
75,992
+18,448
| +32% | +$856K | 0.02% | 498 |
|
|
2021
Q1 | $3.45M | Buy |
57,544
+18,048
| +46% | +$1.08M | 0.03% | 501 |
|
|
2020
Q4 | $2.07M | Buy |
39,496
+28,008
| +244% | +$1.47M | 0.02% | 577 |
|
|
2020
Q3 | $397K | Sell |
11,488
-13,537
| -54% | -$468K | ﹤0.01% | 844 |
|
|
2020
Q2 | $2.17M | Sell |
25,025
-6,480
| -21% | -$562K | 0.02% | 519 |
|
|
2020
Q1 | $1.83M | Sell |
31,505
-2,245
| -7% | -$130K | 0.02% | 499 |
|
|
2019
Q4 | $2.43M | Buy |
+33,750
| New | +$2.43M | 0.02% | 511 |
|
|
2019
Q2 | – | Sell |
-3,450
| Closed | -$280K | – | 1027 |
|
|
2019
Q1 | $280K | Buy |
+3,450
| New | +$280K | ﹤0.01% | 848 |
|